Malaria Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Malaria Epidemiology Forecast Report Coverage

Expert Market Research's “Malaria Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of malaria. It projects the future incidence and prevalence rates of malaria cases across various populations. The study covers age, gender, and type as major determinants of the malaria population. The report highlights patterns in the prevalence of malaria over time and projects future trends based on multiple variables.

Malaria Understanding: Disease Overview

Malaria is a life-threatening infectious disease caused by Plasmodium parasites and transmitted to humans through the bites of infected female Anopheles mosquitoes. The major species responsible for human malaria include Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae, Plasmodium ovale, and Plasmodium knowlesi. The infection primarily affects red blood cells and can cause fever, chills, headache, fatigue, and anemia. Severe cases may lead to organ dysfunction and death, particularly among young children, pregnant women, and individuals with limited immunity. Malaria epidemiology varies considerably across regions depending on transmission intensity and prevention measures.

Key Report Insights

Malaria Epidemiology Perspective

The malaria epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the malaria epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for malaria and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Type-Specific Disease Burden and Epidemiology Analysis

Read more about this report - Request a Free Sample

Country-wise Malaria Epidemiology

The malaria epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

Across the selected countries, malaria epidemiology differs considerably between endemic India and countries where cases are predominantly associated with international travel. In India, opportunities include strengthening early diagnosis, expanding access to rapid diagnostic tests, improving surveillance, and addressing gaps in prevention and treatment in affected communities. In the United States, Germany, France, Italy, Spain, the United Kingdom, and Japan, greater clinical awareness of travel-associated malaria and access to prompt laboratory confirmation remain important priorities. Improved diagnostic readiness and timely species-specific treatment can help reduce complications and prevent avoidable deaths.

Malaria: Treatment Overview

Malaria treatment depends on the infecting Plasmodium species, disease severity, geographic location, and local drug resistance patterns. Artemisinin-based combination therapies are recommended for uncomplicated P. falciparum malaria in many endemic settings. Chloroquine remains an option for infections caused by susceptible parasites, while severe malaria generally requires intravenous artesunate followed by a complete oral treatment course. P. vivax and P. ovale infections may require primaquine or tafenoquine for radical cure to eliminate dormant liver-stage parasites, following appropriate glucose-6-phosphate dehydrogenase deficiency testing. Antimalarial therapy is supported by early diagnosis, appropriate drug selection, and adherence to treatment guidelines.

Key Questions Answered

• What is the current and projected burden of malaria across the 8 major markets?
• Which countries across the 8 major markets account for the highest malaria patient populations and fastest growth rates?
• What is the diagnosed versus undiagnosed patient population of malaria across key countries in the 8 major markets?
• Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of malaria across the 8 major markets?
• What are the major drivers contributing to the increasing burden of malaria across the 8 major markets?
• How do major comorbidities and risk factors influence malaria epidemiology trends across the 8 major markets?
• What are the regional trends in advanced disease progression, treatment uptake, and patient management of malaria across the 8 major markets?
• Which patient segments represent the highest unmet clinical need in the malaria landscape across the 8 major markets?
• Which therapeutic areas linked to malaria are expected to witness the strongest growth opportunities across the 8 major markets?
• How is the malaria epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
• Which countries across the 8 major markets offer the most attractive market opportunities based on malaria epidemiology and healthcare infrastructure?
• Which epidemiological trends are expected to influence future drug development and market access strategies for malaria across the 8 major markets?

Scope of the Malaria Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of malaria based on several factors.
• Malaria Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The malaria report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Malaria Diagnostics Market

Dengue Pipeline Analysis

Dengue Epidemiology Forecast